At a glance
- Originator Nonindustrial source
- Developer Mayoly-Spindler
- Class Antifungals; Antivirals; Macrolides
- Mechanism of Action Cell membrane permeability enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Creutzfeldt-Jakob disease; HIV infections; Mycoses